Among patients with surgically managed orthopedic fractures, treatment of pain with strong opioid medication is not superior to milder medication.
The objective of the study was to determine the frequency of osteoporosis and identify factors associated with a lower bone mineral density in patients with psoriatic arthritis.
Researchers compared bone health in patients with obesity following roux-en-Y gastric bypass and sleeve gastrectomy.
In a post hoc subgroup analysis, researchers assessed the efficacy of denosumab vs risedronate in patients with glucocorticoid-induced osteoporosis and rheumatoid arthritis.
The study authors conducted a nationwide cohort study that included 137,667 Medicare beneficiaries.
The phase 3 ATOM study evaluated the efficacy and safety of abaloparatide in 228 men with osteoporosis.
Postmenopausal bone loss averaged about 10 percent during 25 years of follow-up in a random sample of women.
Researchers determined the correlation between vascular pathophysiology and bone metabolism in patients with rheumatoid arthritis and ankylosing spondylitis.
Zoledronic acid, an annual intravenous therapy for osteoporosis, sometimes causes acute-phase reactions such as fever, myalgia, and flu-like symptoms after infusion. Researchers wondered if these initial transient reactions could be used as a predictor of the drug’s efficacy in people at risk for fractures.
Increasing intake of calcium and protein using dairy foods is associated with a reduction in falls and fractures among institutionalized older adults.